The Hidden Accelerator: Why Team Performance is Biotech's most Underused AdvantagePosted on January 23, 2026 |
February 4, 2026, 3:00 – 4:00 p.m. EST
Presented by Anissa Davenport, MBA , Brooke Hynes, MA and David Eilers of Possibility Partners, LLC
Register in advance for this Webex Meeting here.
Biotech companies rightly invest in breakthrough technology, go-to-market strategy, and fundraising. Yet there is another key accelerator hiding in plain sight: team performance. High-functioning teams speed decision-making, improve execution and manage change across the enterprise. Our discussion will explore how intentional team design and culture development can drive efficiency from R&D to commercialization, drawing on real-world examples and organizational research. Attendees will learn practical ways to activate the conditions of success for high-performing teams. Given that 75% of cross-functional teams are underperforming, this is a chance to accelerate your work, meet your development milestones and advance your organization in a competitive industry.
Other Member News

January 23, 2026Nave Law Firm Announces Formation of Legal Management Committee to Strengthen Governance and Client ServiceThe Legal Management Committee brings together elected attorney leaders and appointed non-attorney executives to guide the firm’s strategic direction while preserving attorney authority over legal decision-making. |
